Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Conditions: Pneumococcal Vaccines Interventions: Biological: IVT PCV-25 Formulation A; Biological: IVT PCV-25 Formulation B; Biological: IVT PCV-25 Formulation C; Biological: PCV 20 Sponsors: Inventprise Inc.; Canadian Center for Vaccinology; Vaccine Evaluation Center, Canada; PATH Not yet recruiting

https://clinicaltrials.gov/study/NCT06077656

Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials